Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VDAC2 pseudogene 3 (VDAC2P3) is a human pseudogene resembling the genomic structure of the VDAC2 gene, which encodes the voltage-dependent anion channel protein 2, but VDAC2P3 is non-coding and does not produce a functional protein. No expression or biological function has been documented for VDAC2P3, and there is no evidence linking it to human disease or therapeutic interventions. It is considered a processed or unprocessed genomic relic without current biomedical relevance[4]. Key clarifications: - This gene is not the same as the functional "Voltage-dependent anion-selective channel protein 2" (VDAC2). - There are multiple VDAC pseudogenes in the human genome, but VDAC2P3 is not expressed or functionally characterized. - All reported molecular functions, disease roles, or drug interactions for the VDAC2 gene do not apply to this pseudogene form[4]. Summary: VDAC2P3 is not a protein-coding gene, is not a therapeutic target, and should not be confused with the functional VDAC2 channel protein[4].
None (not a functional protein/receptor/enzyme/transporter, etc.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VDAC2 pseudogene 3 (VDAC2P3).